Suchbegriffe: TUMOR MARKERS, BIOLOGICAL - GENETICS, . Treffer: 37
Szkandera, J; Pichler, M; Absenger, G; Stotz, M; Weissmueller, M; Samonigg, H; Asslaber, M; Lax, S; Leitner, G; Winder, T; Renner, W; Gerger, A
A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients.
Clin Cancer Res. 2014; 20(6):1687-1697
Doi: 10.1158/1078-0432.CCR-13-1517
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Absenger, G; Szkandera, J; Stotz, M; Pichler, M; Winder, T; Langsenlehner, T; Langsenlehner, U; Samonigg, H; Renner, W; Gerger, A
A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
Mol Carcinog. 2013; 52 Suppl 1(9):E96-102
Doi: 10.1002/mc.22028
Web of Science
PubMed
FullText
FullText_MUG
Fogeron, ML; Muller, H; Schade, S; Dreher, F; Lehmann, V; Kuhnel, A; Scholz, AK; Kashofer, K; Zerck, A; Fauler, B; Lurz, R; Herwig, R; Zatloukal, K; Lehrach, H; Gobom, J; Nordhoff, E; Lange, BMH;
LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells.
NAT COMMUN. 2013; 4(2): 1531-1531.
Doi: 10.1038/ncomms2517
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Porpaczy, E; Tauber, S; Bilban, M; Kostner, G; Gruber, M; Eder, S; Heintel, D; Le, T; Fleiss, K; Skrabs, C; Shehata, M; Jager, U; Vanura, K;
Lipoprotein lipase in chronic lymphocytic leukaemia - Strong biomarker with lack of functional significance.
LEUK RES. 2013; 37(6): 631-636.
Doi: 10.1016/j.leukres.2013.02.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Senanayake, U; Koller, K; Pichler, M; Leuschner, I; Strohmaier, H; Hadler, U; Das, S; Hoefler, G; Guertl, B
The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration.
Hum Pathol. 2013; 44(3):336-345
Doi: 10.1016/j.humpath.2012.05.021
Web of Science
PubMed
FullText
FullText_MUG
Szkandera, J; Absenger, G; Pichler, M; Stotz, M; Langsenlehner, T; Samonigg, H; Renner, W; Gerger, A
Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.
J Cancer Res Clin Oncol. 2013; 139(9):1457-1464
Doi: 10.1007/s00432-013-1461-x
Web of Science
PubMed
FullText
FullText_MUG
Ye, M; Zhang, H; Amabile, G; Yang, H; Staber, PB; Zhang, P; Levantini, E; Alberich-Jorda, M; Zhang, JY; Kawasaki, A; Tenen, DG;
C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence.
Nat Cell Biol. 2013; 15(4):385-394
Doi: 10.1038/ncb2698
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fried, I; Bodner, C; Pichler, MM; Lind, K; Beham-Schmid, C; Quehenberger, F; Sperr, WR; Linkesch, W; Sill, H; Wölfler, A
Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.
Haematologica. 2012; 97(2):246-250
Doi: 10.3324/haematol.2011.051581
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gilg, MM; Mrak, K; Vieth, M; Langner, C
Granular cell tumor of the stomach.
Pathologe. 2012; 33(1):61-64
Doi: 10.1007/s00292-011-1547-7
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Rinner, B; Froehlich, EV; Buerger, K; Knausz, H; Lohberger, B; Scheipl, S; Fischer, C; Leithner, A; Guelly, C; Trajanoski, S; Szuhai, K; Liegl, B
Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
Int J Oncol. 2012; 40(2): 443-451.
Doi: 10.3892/ijo.2011.1235
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Auprich, M; Bjartell, A; Chun, FK; de la Taille, A; Freedland, SJ; Haese, A; Schalken, J; Stenzl, A; Tombal, B; van der Poel, H
Contemporary role of prostate cancer antigen 3 in the management of prostate cancer.
Eur Urol. 2011; 60(5):1045-1054
Doi: 10.1016/j.eururo.2011.08.003
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Betge, J; Pollheimer, MJ; Schlemmer, A; Hoefler, G; Langner, C
Gastric cancer and concomitant renal cancer: a systematic immunohistochemical and molecular analysis.
Oncol Rep. 2011; 26(3):567-575
Doi: 10.3892/or.2011.1346
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gerger, A; Labonte, M; Lenz, HJ
Molecular predictors of response to antiangiogenesis therapies.
Cancer J. 2011; 17(2):134-141
Doi: 10.1097/PPO.0b013e318212db3c
Web of Science
PubMed
FullText
FullText_MUG
Balic, M; Williams, A; Dandachi, N; Cote, RJ
Micrometastasis: detection methods and clinical importance.
Cancer Biomark. 2010; 9(1-6):397-419
Doi: 10.3233/CBM-2011-0161
Web of Science
PubMed
FullText
FullText_MUG
Birkhahn, M; Mitra, AP; Williams, AJ; Lam, G; Ye, W; Datar, RH; Balic, M; Groshen, S; Steven, KE; Cote, RJ
Predicting recurrence and progression of noninvasive papillary bladder cancer at initial presentation based on quantitative gene expression profiles.
Eur Urol. 2010; 57(1):12-20
Doi: 10.1016/j.eururo.2009.09.013
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pirker, R; Herth, FJ; Kerr, KM; Filipits, M; Taron, M; Gandara, D; Hirsch, FR; Grunenwald, D; Popper, H; Smit, E; Dietel, M; Marchetti, A; Manegold, C; Schirmacher, P; Thomas, M; Rosell, R; Cappuzzo, F; Stahel, R; European EGFR Workshop Group
Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
J Thorac Oncol. 2010; 5(10): 1706-1713.
Doi: 10.1097/JTO.0b013e3181f1c8de
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Google Scholar
Pristauz, G; Petru, E; Stacher, E; Geigl, JB; Schwarzbraun, T; Tsybrovskyy, O; Winter, R; Moinfar, F
Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations.
Histopathology. 2010; 57(6):877-884
Doi: 10.1111/j.1365-2559.2010.03724.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Symmans, WF; Hatzis, C; Sotiriou, C; Andre, F; Peintinger, F; Regitnig, P; Daxenbichler, G; Desmedt, C; Domont, J; Marth, C; Delaloge, S; Bauernhofer, T; Valero, V; Booser, DJ; Hortobagyi, GN; Pusztai, L
Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer.
J Clin Oncol. 2010; 28(27): 4111-4119.
Doi: 10.1200/JCO.2010.28.4273
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Voortman, J; Goto, A; Mendiboure, J; Sohn, JJ; Schetter, AJ; Saito, M; Dunant, A; Pham, TC; Petrini, I; Lee, A; Khan, MA; Hainaut, P; Pignon, JP; Brambilla, E; Popper, HH; Filipits, M; Harris, CC; Giaccone, G
MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma.
Cancer Res. 2010; 70(21): 8288-8298.
Doi: 10.1158/0008-5472.CAN-10-1348
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fröhlich, E; Maier, E; Mack, AF; Garbe, C
Dipeptidyl peptidase II is not a marker for progression in melanoma.
J Dermatol Sci. 2009; 53(1): 68-71.
Doi: 10.1016/j.jdermsci.2008.07.014
Web of Science
PubMed
FullText
FullText_MUG
Gutwein, P; Schramme, A; Sinke, N; Abdel-Bakky, MS; Voss, B; Obermüller, N; Doberstein, K; Koziolek, M; Fritzsche, F; Johannsen, M; Jung, K; Schaider, H; Altevogt, P; Ludwig, A; Pfeilschifter, J; Kristiansen, G
Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients.
Eur J Cancer. 2009; 45(3): 478-489.
Doi: 10.1016/j.ejca.2008.10.023
Web of Science
PubMed
FullText
FullText_MUG
Ploner, F; Zacherl, J; Wrba, F; Längle, F; Bareck, E; Eisterer, W; Kühr, T; Schima, W; Häfner, M; Brodowicz, T; für das österreichische GIST-Panel
Gastrointestinal stromal tumors: recommendations for diagnosis, treatment and aftercare in Austria
Wien Med Wochenschr. 2009; 159(15-16): 370-382.
Doi: 10.1007/s10354-009-0685-5
PubMed
FullText
FullText_MUG
Ugurel, S; Utikal, J; Becker, JC
Tumor biomarkers in melanoma.
Cancer Control. 2009; 16(3):219-224
Doi: 10.1177/107327480901600303
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wygrecka, M; Marsh, LM; Morty, RE; Henneke, I; Guenther, A; Lohmeyer, J; Markart, P; Preissner, KT
Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung.
Blood. 2009; 113(22): 5588-5598.
Doi: 10.1182/blood-2008-08-170837
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dacic, S; Kothmaier, H; Land, S; Shuai, Y; Halbwedl, I; Morbini, P; Murer, B; Comin, C; Galateau-Salle, F; Demirag, F; Zeren, H; Attanoos, R; Gibbs, A; Cagle, P; Popper, H
Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas.
Virchows Arch. 2008; 453(6): 627-635.
Doi: 10.1007/s00428-008-0689-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Fiegel, HC; Kaifi, JT; Quaas, A; Varol, E; Krickhahn, A; Metzger, R; Sauter, G; Till, H; Izbicki, JR; Erttmann, R; Kluth, D
Lack of Thy1 (CD90) expression in neuroblastomas is correlated with impaired survival
Pediatr Surg Int. 2008; 24(1):101-105
Doi: 10.1007/s00383-007-2033-4
Web of Science
PubMed
FullText
FullText_MUG
Hofmann, G; Langsenlehner, U; Renner, W; Langsenlehner, T; Yazdani-Biuki, B; Clar, H; Gerger, A; Wehrschuetz, M; Samonigg, H; Krippl, P
Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk.
J Cancer Res Clin Oncol. 2008; 134(5):591-595
Doi: 10.1007/s00432-007-0322-x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P
A multigenic approach to predict breast cancer risk.
Breast Cancer Res Treat. 2007; 104(2):159-164
Doi: 10.1007/s10549-006-9408-4
Web of Science
PubMed
FullText
FullText_MUG
Kidd, M; Nadler, B; Mane, S; Eick, G; Malfertheiner, M; Champaneria, M; Pfragner, R; Modlin, I
GeneChip, geNorm, and gastrointestinal tumors: novel reference genes for real-time PCR.
PHYSIOL GENOMICS. 2007; 30(3): 363-370.
Doi: 10.1152/physiolgenomics.00251.2006
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Olaussen, KA; Dunant, A; Fouret, P; Brambilla, E; André, F; Haddad, V; Taranchon, E; Filipits, M; Pirker, R; Popper, HH; Stahel, R; Sabatier, L; Pignon, JP; Tursz, T; Le Chevalier, T; Soria, JC; IALT Bio Investigators
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy.
N ENGL J MED. 2006; 355: 983-991.
Doi: 10.1056/NEJMoa060570
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pashenkov, M; Goëss, G; Wagner, C; Hörmann, M; Jandl, T; Moser, A; Britten, CM; Smolle, J; Koller, S; Mauch, C; Tantcheva-Poor, I; Grabbe, S; Loquai, C; Esser, S; Franckson, T; Schneeberger, A; Haarmann, C; Krieg, AM; Stingl, G; Wagner, SN
Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
J CLIN ONCOL. 2006; 24(36): 5716-5724.
Doi: 10.1200/JCO.2006.07.9129
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ullmann, R; Morbini, P; Halbwedl, I; Bongiovanni, M; Gogg-Kammerer, M; Papotti, M; Gabor, S; Renner, H; Popper, HH
Protein expression profiles in adenocarcinomas and squamous cell carcinomas of the lung generated using tissue microarrays.
J PATHOL. 2004; 203(3): 798-807.
Doi: 10.1002/path.1584
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Zigeuner, R; Ratschek, M; Rehak, P; Schips, L; Langner, C
Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
UROLOGY. 2004; 63(4): 651-655.
Doi: 10.1016/j.urology.2003.11.011
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Sasaki, H; Lo, KM; Chen, LB; Auclair, D; Nakashima, Y; Moriyama, S; Fukai, I; Tam, C; Loda, M; Fujii, Y
Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.
Jpn J Cancer Res. 2001; 92(8): 869-873.
Doi: 10.1111/j.1349-7006.2001.tb01174.x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hasselmann, DO; Rappl, G; Rössler, M; Ugurel, S; Tilgen, W; Reinhold, U
Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.
Oncol Rep. 2000; 8(1):115-118
Web of Science
PubMed
Erttmann, R; Tafese, T; Berthold, F; Kerbl, R; Mann, J; Parker, L; Schilling, F; Ambros, P; Christiansen, H; Favrot, M; Kabisch, H; Hero, B; Philip, T
10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).
Eur J Cancer. 1998; 34(9):1391-1397
Doi: 10.1016%2FS0959-8049%2898%2900135-X
Web of Science
PubMed
FullText
FullText_MUG
Zoubek, A; Pfleiderer, C; Ambros, PF; Kronberger, M; Dworzak, MN; Gruber, B; Luegmayer, A; Windhager, R; Fink, FM; Urban, C
Minimal metastatic and minimal residual disease in patients with Ewing tumors
Klin Padiatr. 1995; 207(4):242-247
Doi: 10.1055/s-2008-1046548
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar